You are here

US pharma deal set to boost sales for Japan's Sawai family


FOR decades, Japan's Sawai family was content to keep the drug business they founded focused on its home market. Now, they are steering the country's second-biggest maker of generic drugs through its first overseas acquisition in its 88-year history.

Sawai Pharmaceutical Co,...

Market voices on: